Blackmores to sell Global Therapeutics for $27 million

Blackmores to sell Global Therapeutics for $27 million

Blackmores (ASX: BKL) has today confirmed the divestment of subsidiary Global Therapeutics for $27 million to health company McPherson's Limited (ASX: MCP).

The sale of the business, known for its Fusion Health and Oriental Botanicals brands, comes just over four years after Blackmores acquired the company.

The divestment of Global Therapeutics, which focuses on traditional Chinese medicine in combination with contemporary herbal treatments, follows a review of the Blackmores portfolio by CEO Alastair Symington.

In February, Symington announced to shareholders the company would be divesting non-core brands from the portfolio.

"Fusion Health and Oriental Botanicals are wonderful brands which play an important role in the health and wellness routine of many Australians," said Symington.

"While we have decided that Global Therapeutics is no longer part of our strategic priorities, I want to acknowledge the unique value of these brands and believe Global Therapeutics will now have an opportunity to reach its true potential with McPherson's."

To fund the acquisition McPherson's is embarking on a $36.5 million capital raise via the issuance of 16.1 million shares at an 8.1 per cent discount to the last closing price on Monday, 26 October.

In addition, a further $10 million will be raised via a non-underwritten share purchase plan.

"Building on McPherson's 160-year rich history and our strategic focus on health, wellbeing and beauty categories, has recently seen us establish a new health and wellness division within McPherson's," said McPherson's CEO and managing director Laurence McAllister.

"Acquiring Global Therapeutics embeds a strong vitamins and dietary supplements business in that division with recognised brands, a go to market capability and a strong product innovation pipeline.

"We have been very impressed with the passion and capability of the Global Therapeutics team and we look forward to growing the business in partnership with this highly engaged group."

The transaction is due for completion on 30 November.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Enjoyed this article?

Don't miss out on the knowledge and insights to be gained from our daily news and features.

Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.

Support independent journalism and stay informed with stories that matter to you.

Subscribe now and get 50% off your first year!

Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

REA Group buys full stake in end-to-end property sales interface Realtair

REA Group buys full stake in end-to-end property sales interface Realtair

Realestate.com.au operator REA Group (ASX: REA) has acquired the re...

HESTA to pump $250m into new global fund with Stafford Capital Partners

HESTA to pump $250m into new global fund with Stafford Capital Partners

Strong returns over the past three years from a $200 million global...

Breakthrough Victoria up to the test with $15m investment in Liquid Instruments

Breakthrough Victoria up to the test with $15m investment in Liquid Instruments

A Canberra-born, San Diego-headquartered technology company that re...

Pacific Smiles to extend nib dental offering to all centres

Pacific Smiles to extend nib dental offering to all centres

Takeover target Pacific Smiles (ASX: PSQ) may see its clinics filli...